Palo Alto Investors

Palo Alto Investors as of March 31, 2019

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 37 positions in its portfolio as reported in the March 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
BioMarin Pharmaceutical (BMRN) 9.8 $235M 2.6M 88.83
Insmed (INSM) 9.3 $223M 7.7M 29.07
Abiomed 8.3 $200M 699k 285.59
United Therapeutics Corporation (UTHR) 8.0 $192M 1.6M 117.37
Alexion Pharmaceuticals 6.9 $166M 1.2M 135.18
STAAR Surgical Company (STAA) 6.0 $144M 4.2M 34.19
Sage Therapeutics (SAGE) 5.7 $136M 858k 159.05
Clovis Oncology 5.4 $130M 5.2M 24.82
Immunomedics 5.1 $123M 6.4M 19.21
Amicus Therapeutics (FOLD) 4.3 $104M 7.6M 13.60
Vanda Pharmaceuticals (VNDA) 3.9 $93M 5.1M 18.40
Wright Medical Group Nv 3.6 $87M 2.8M 31.45
Epizyme 3.6 $86M 6.9M 12.39
Aimmune Therapeutics 3.5 $84M 3.7M 22.35
Acadia Healthcare (ACHC) 2.5 $60M 2.2M 26.85
Align Technology (ALGN) 2.0 $47M 165k 284.33
Puma Biotechnology (PBYI) 1.9 $46M 1.2M 38.79
AMAG Pharmaceuticals 1.8 $44M 3.4M 12.88
Karyopharm Therapeutics (KPTI) 1.3 $31M 5.3M 5.84
EXACT Sciences Corporation (EXAS) 1.1 $27M 315k 86.62
Momenta Pharmaceuticals 1.1 $27M 1.8M 14.53
Alder Biopharmaceuticals 1.1 $25M 1.9M 13.65
Celgene Corporation 1.1 $25M 266k 94.34
Prothena (PRTA) 0.6 $13M 1.1M 12.13
Kaleido Biosciences Ord (KLDO) 0.5 $13M 867k 14.50
Gilead Sciences (GILD) 0.5 $11M 176k 65.01
Rigel Pharmaceuticals (RIGL) 0.4 $10M 4.0M 2.57
Dicerna Pharmaceuticals 0.3 $7.3M 501k 14.65
Alimera Sciences 0.1 $3.2M 3.0M 1.06
Zogenix 0.1 $1.6M 30k 55.02
Sunesis Pharmaceuticals Inc Ne 0.1 $1.4M 1.2M 1.21
Cytokinetics (CYTK) 0.0 $1.0M 124k 8.09
Marinus Pharmaceuticals 0.0 $477k 114k 4.18
Sophiris Bio 0.0 $245k 247k 0.99
Idera Pharmaceuticals 0.0 $196k 77k 2.54
Histogenics Corp Cmn 0.0 $36k 303k 0.12
Melinta Therapeutics 0.0 $36k 10k 3.55